MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18
Open accessThe DOI matches its Crossref record; 42 of the 44 references it cites were found in a registry or an index.
Abstract
Signaling through the adaptor protein myeloid differentiation factor 88 (MyD88) promotes carcinogenesis in several cancer models. In contrast, MyD88 signaling has a protective role in the development of azoxymethane (AOM)/dextran sodium sulfate (DSS) colitis-associated cancer (CAC). The inability of Myd88(-/-) mice to heal ulcers generated upon injury creates an altered inflammatory environment that induces early alterations in expression of genes encoding proinflammatory factors, as well as pathways regulating cell proliferation, apoptosis, and DNA repair, resulting in a dramatic increase in adenoma formation and progression to infiltrating adenocarcinomas with frequent clonal mutations in the beta-catenin gene. Others have reported that toll-like receptor (Tlr) 4-deficient mice have a similar susceptibility to colitis to Myd88-deficient mice but, unlike the latter, are resistant to CAC. We have observed that mice deficient for Tlr2 or Il1r do not show a differential susceptibility to colitis or CAC. However, upon AOM/DSS treatment Il18(-/-) and Il18r1(-/-) mice were more susceptible to colitis and polyp formation than wild-type mice, suggesting that the phenotype of Myd88(-/-) mice is, in part, a result of their inability to signal through the IL-18 receptor. This study revealed a previously unknown level of complexity surrounding MyD88 activities downstream of different receptors that impact tissue homeostasis and carcinogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In fact, IL-18 KO or IL-18R KO mice are also highly sensitive to colitis-associated CRC [124,125].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [125]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383 · cited 4×
“We observed enhanced expression of several known STAT3-dependent genes (Yu et al., 2009) in addition to Il6 and Il11 in AOM/DSS-treated Myd88/ mice, including Cox2, Hif1a, and several metalloproteases.”
BackgroundInfluentialRecognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251 · cited 2×
“RESULTS Myd88/ mice show increased susceptibility to develop colonic tumors after AOM/DSS administration Myd88/ mice are highly susceptible to the development of colitis induced by irradiation or DSS as a result of reduced ability to repair the mucosal integrity after injury with significant morbidity and mortalit…”
BackgroundIKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.001 · Cited by 2,155 · cited 2×
“STAT3 activation in both epithelial cells and in stromal and infiltrating cells has been shown to regulate the tumor inflammatory environment as well as to have direct effects on the tumor itself by inducing antiapoptotic, proangiogenic, and proproliferative gene expression programs (Grivennikov et al., 2009; Yu et al…”
BackgroundSystematic variation in gene expression patterns in human cancer cell lines
Ross, D. T., Scherf, U., Eisen, M. B., Perou, C. M., Rees, C., Spellman, P., Iyer, V., Jeffrey, S. S., Van de Rijn, M., Waltham, M., et al. (2000) · Nature Genetics · doi:10.1038/73432 · Cited by 2,088
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
Naugler, W. E., Sakurai, T., Kim, S., Maeda, S., Kim, K., Elsharkawy, A. M., & Karin, M. (2007) · Science · doi:10.1126/science.1140485 · Cited by 1,955
Landon, M., Saam, J., Brown, K. L., Moyes, K., Evans, B., & Wenstrup, R. (2015) · Oncology · doi:10.1159/000430097 · Cited by 1,939
Interferons, immunity and cancer immunoediting
Dunn, G. P., Koebel, C. M., & Schreiber, R. D. (2006) · Nature Reviews Immunology · doi:10.1038/nri1961 · Cited by 1,617 · cited 2×
“…and Il18/ mice to colon carcinogenesis might exclusively be the result of the lack of an immunosurveillance effect of adaptive immunity and IFN- (Dunn et al., 2006), particularly when it is considered that Rag/ immunodeficient mice have reduced rather than increased susceptibility to colon…”
BackgroundStabilization of β-Catenin by Genetic Defects in Melanoma Cell Lines
Rubinfeld, B., Robbins, P., El-Gamil, M., Albert, I., Porfiri, E., & Polakis, P. (1997) · Science · doi:10.1126/science.275.5307.1790 · Cited by 1,223
Cited by
Items 301–400 of 451
Cardone, M., Dzutsev, A. K., Li, H., Riteau, N., Gerosa, F., Shenderov, K., Winkler-Pickett, R., Provezza, L., Riboldi, E., Leighty, R. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114516 · Cited by 17
“Real-Time qRT-PCR was performed [64] using specific primers (Table S2 in File S1) for the detection of primary and mature transcripts.”
MethodSelf-citationMyeloid translocation genes differentially regulate colorectal cancer programs
Parang, B., Bradley, A. M., Mittal, M. K., Short, S. P., Thompson, J. J., Barrett, C. W., Naik, R. D., Bilotta, A. J., Washington, M. K., Revetta, F. L., et al. (2016) · Oncogene · doi:10.1038/onc.2016.167 · Cited by 17
“For example, loss of Mmp9 or Myd88 promotes inflammatory carcinogenesis in the AOM/DSS model 41,42 , but loss of either inhibits tumorigenesis in the Apc Min model of sporadic colorectal cancer 43,44 .”
Lai, X., & Egan, L. J. (2013) · Oncogenesis · doi:10.1038/oncsis.2013.22 · Cited by 17
Scarpa, M., Cardin, R., Bortolami, M., Kotsafti, A., Scarpa, M. C., Pozza, A., Maran, G., Piciocchi, M., Ruffolo, C., Renata D'Incà, et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.05.015 · Cited by 17
“Repair mechanisms of damaged mucosa could involve TLR4 signalling causing an inhibition of proliferation of epithelial cells.(41) A snapshot of the human colonic mucosa during UC-related inflammatory and non-inflammatory carcinogenesis processes, the study’s main limitation is its observational design.”
BackgroundMicrobiota in digestive cancers: our new partner?
Lopez, A., Hansmannel, F., Kökten, T., Bronowicki, J., Melhem, H., Sokol, H., & Peyrin‐Biroulet, L. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx087 · Cited by 16
“In mice with intestinal dysbiosis characterized by a proportional expansion of the bacterial phyla Bacteroidetes, production of the proinflammatory cytokine IL-18, implied in mediation of mucosal protective mechanisms, is decreased, leading to elevated susceptibility to chemically induced colon carcinogenesis (17).”
BackgroundZhu, J., Liu, C., Teng, X., Yin, J., Zheng, L., Wang, L., Tang, W., Gu, H., Gu, B., & Chen, L. (2015) · Biomedical Reports · doi:10.3892/br.2015.552 · Cited by 15
“IL-18 IL-18 has a critical role in MyD88-mediated signaling to prevent colon adenocarcinoma development (11).”
Holding the inflammatory system in check: NLRs keep it cool
Jha, S., & Ting, J. P.-Y. (2015) · F1000Prime Reports · doi:10.12703/p7-15 · Cited by 17
Hernandez, Y., Sotolongo, J. P., & Fukata, M. (2011) · Cancers · doi:10.3390/cancers3033104 · Cited by 14
“Therefore, the influences of other upstream signaling that share the MyD88 pathway with TLR4 need to be explored [39-42].”
Levy, E. H., Marcil, V., Baumel, S. T. É., Dahan, N., DELVIN, E. E., & Spahis, S. (2023) · Nutrients · doi:10.3390/nu15061394 · Cited by 16
“This cytokine is known to produce a protective effect against enterocyte inflammation and colitis [213,214], which is supported by the susceptibility of IL-18 knockout mice and IL-18 receptor knockout mice to colitis [214].”
BackgroundCharepalli, V., Reddivari, L., Radhakrishnan, S., Eriksson, E., Xiao, X., Kim, S. W., Shen, F. H., Vijay–Kumar, M., Li, Q., Bhat, V. B., et al. (2017) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-17-0010 · Cited by 14
“Recent research has shown that NF-kB plays a role in epithelial cell proliferation by increasing nuclear b-catenin accumulation upon exposure to innate inflammation, such as in colitis (35).”
BackgroundHoltorf, A., Conrad, A., Holzmann, B., & Janssen, K. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1466770 · Cited by 15
“MyD88-dependent signaling was found to prevent lesion formation upon chemical induced inflammation and carcinogenesis (AOM/DSS treatment).(11) Moreover, MyD88 has been described to dampen the development of Helicobacter-induced gastric malignancies.”
BackgroundProteus mirabilis: The Enemy Within
Dzutsev, A., & Trinchieri, G. (2015) · Immunity · doi:10.1016/j.immuni.2015.04.004 · Cited by 14
“…shown that IL-18 has an important protective role on the colonic mucosa and that Il18 / mice unable to produce the cytokine, as well as Il18r / and Myd88 / mice, unable to respond to the cytokine, showed enhanced susceptibility to DSS and induce colitis and tumor promotion (Salcedo et al., 2010).”
BackgroundSelf-citationInflammasomes in Intestinal Disease: Mechanisms of Activation and Therapeutic Strategies
Scalavino, V., Piccinno, E., Giannelli, G., & Serino, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313058 · Cited by 13
“The lack of both the IL-1 β and IL-18 receptors causes a greater susceptibility to DSS-induced colitis and CRC development [95].”
STING signalling: an emerging common pathway in autoimmunity and cancer
McCaffary, D. (2017) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2017.1350704 · Cited by 13
THE ROLE OF INNATE IMMUNITY FACTORS IN TUMORIGENESIS PROCESS
Свитич, О. А., Филина, А. Б., Davydova, N. V., Gankovskaya, L. V., & Zverev, V. V. (2018) · Medical Immunology (Russia) · doi:10.15789/1563-0625-2018-2-151-162 · Cited by 12
Dawod, B., Haidl, I. D., Azad, M. B., & Marshall, J. S. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.01.049 · Cited by 12
Chen, J., Xia, D., Xu, M., Su, R., Lin, W., Guo, D., Chen, G., & Liu, S. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00559 · Cited by 12
Polymorphisms of Interlukin-1β rs16944 confer susceptibility to myelodysplastic syndromes
Yin, C., He, N., Li, P., Zhang, C., Yu, J., Hua, M., Ji, C., & Ma, D. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.09.019 · Cited by 12
Inflammatory bowel disease: recent advances on genetics and innate immunity.
Karantanos, T., & Gazouli, M. (2011) · PubMed Central · Cited by 21
Unlocking IL-18: A hidden key in cancer immunity
Manesh, S. S., Debeaud, M., & Vouret‐Craviari, V. (2025) · Seminars in Immunology · doi:10.1016/j.smim.2025.101997 · Cited by 12
Xie, B., Wang, B., Shang, R., Wang, L., Huang, X., & Xie, L. (2023) · Scientific Reports · doi:10.1038/s41598-023-49457-8 · Cited by 11
“MyD88 −/− mice are more susceptible to AOM/DSS-induced colitis and form more polyps and have histological characteristics of more aggressive adenomas and carcinomas 46 .”
BackgroundThe diagnostic and prognostic role of cytokines in colon cancer
Raufman, J., & Long (2011) · Gastrointestinal Cancer Targets and Therapy · doi:10.2147/gictt.s18423 · Cited by 14
“This same study argues against the ability of IL-1Β signaling to affect disease severity because in DSS/AOM-treated IL-1R-/- mice there was no change in colitis or neoplasia.(24)”
BackgroundHolmkvist, P., Pool, L., Hägerbrand, K., Agace, W. W., & Rivollier, A. (2016) · European Journal of Immunology · doi:10.1002/eji.201545957 · Cited by 12
Baliou, S., Adamaki, M., Spandidos, D. A., Kyriakopoulos, A. M., Christodoulou, I., & Zoumpourlis, V. C. (2018) · World Academy of Sciences Journal · doi:10.3892/wasj.2018.6 · Cited by 11
Tsuda, M., Noguchi, M., Kurai, T., Ichihashi, Y., Ise, K., Wang, L., Ishida, Y., Tanino, M. A., Hirano, S., Asaka, M., et al. (2021) · Cancer Science · doi:10.1111/cas.15157 · Cited by 11
Molecular Interactions in Interleukin and Toll-like Receptor Signaling Pathways
Snyder, G. A., & Sundberg, E. J. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990069 · Cited by 11
Pyroptosis: Turning Up the Heat on Cancer
Zhang, Z., & Lieberman, J. (2026) · Annual Review of Immunology · doi:10.1146/annurev-immunol-082423-041848 · Cited by 10
Predictive Values of Colon Microbiota in the Treatment Response to Colorectal Cancer
Ros, J. G., Ramos-Arenas, V., & Conesa‐Zamora, P. (2020) · Pharmacogenomics · doi:10.2217/pgs-2020-0044 · Cited by 9
NLRP1 in Cutaneous SCCs: An Example of the Complex Roles of Inflammasomes in Cancer Development
Filippo, M. D., Hennig, P., Karakaya, T., Slaufova, M., & Beer, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012308 · Cited by 10
“At least in these models, IL-18 rather than IL-1 seems to have a key protective role, as it supports the repair of the colonic epithelium after injury [25,26,98].”
BackgroundBachmann, M., Pfeilschifter, J. M., & Mühl, H. (2018) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2018.01.020 · Cited by 9
Microbiome and Colorectal Cancer
Ahmed, I., & Umar, S. (2018) · Current Colorectal Cancer Reports · doi:10.1007/s11888-018-0416-7 · Cited by 12
Ghosh, S., Vanwinkle, Z. M., Bodduluri, S. R., Juin, S. K., Kadari, M., Singh, A., Dryden, G. W., Lawrenz, M. B., Kanneganti, T., Rai, S. N., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-73760-3 · Cited by 8
“Nlrp6 − / − and Il18 − / − mice are also more susceptible to DSS-induced colitis, indicating their importance in maintaining gut homeostasis 53,78 – 81 .”
Host–Viral Interactions in the Pathogenesis of Ulcerative Colitis
Bruland, T., Østvik, A. E., Sandvik, A. K., & Hansen, M. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910851 · Cited by 10
“A basal level of IL-18 in the colonic mucosa is required to maintain barrier integrity since the complete loss of IL-18 predisposes mice to intestinal epithelial damage, fostering an altered inflammatory environment that potentiates intestinal tumor formation [111,112].”
BackgroundRole of STAT3 in Colorectal Cancer Development
Lakkim, V., Reddy, M. C., Prasad, D. V. R., & Lomada, D. (2017) · Springer eBooks · doi:10.1007/978-981-10-6728-0_19 · Cited by 8
Khare, S., Jog, R., Bright, A., Burgess, D. J., Chakder, S., & Gokulan, K. (2023) · Nanotoxicology · doi:10.1080/17435390.2023.2289940 · Cited by 8
“In contrast, a limited number of studies have shown that IL-18 in fact protects the intestinal epithelial cells from inflammation and colitis development (Salcedo et al. 2010).”
BackgroundInflammasomes in the Gut Mucosal Homeostasis
Yao, X., & Meng, G. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-5987-2_6 · Cited by 8
Deleting MyD88 signaling in myeloid cells promotes development of adenocarcinomas of the colon
Song, J., Chen, Z., Geng, T., Wang, M., Yi, S., Liu, K., Zhou, W., Gao, J., Song, W., & Tang, H. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.06.036 · Cited by 10
TLR signaling: a link between gut microflora, colorectal inflammation and tumorigenesis
Santaolalla, R., Sussman, D. A., & Abreu, M. T. (2011) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2012.02.002 · Cited by 9
The broad impact of cell death genes on the human disease phenome
Rich, A., Lin, P., Gamazon, E. R., & Zinkel, S. S. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06632-7 · Cited by 7
SIGIRR, a negative regulator of colon tumorigenesis
Zhao, J., Zepp, J. A., Bulek, K., & Li, X. (2011) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2012.02.003 · Cited by 7
“IL-18 knockout mice share the similar phenotypes with MyD88 deficient mice in the AOM/DSS induced colon cancer model, displaying increased tumor formation and growth [22].”
BackgroundChen, J., He, J., Yang, Y., & Jiang, J. (2018) · Oncology Letters · doi:10.3892/ol.2018.9297 · Cited by 7
“Myeloid differentiation factor 88 (MyD88) has been demonstrated to contribute to the occurrence and development of multiple types of tumors, including breast (3), ovarian (4), liver (5), pancreatic and colon (6,7) cancer.”
BackgroundSalman, T., Varol, U., Yıldız, İ., Küçükzeybek, Y., & Alacacıoğlu, A. (2015) · Acta Oncologica Turcica · doi:10.5505/aot.2015.49368 · Cited by 8
Hossam, N., Matboli, M., Shehata, H. H., Aboelhussein, M. M., Hassan, M. K., & Eissa, S. (2020) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2020.1816136 · Cited by 7
Lv, L., Zhang, Y., Kong, R., Wang, C., Wang, X., & Zhou, X. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05018-0 · Cited by 6
“For example, the release of IL-1 β and IL-18 may facilitate the occurrence and progression of tumors (Hu et al. 2010, Salcedo et al. 2010).”
BackgroundCytokines and Inflammatory Bowel Disease
de Zoeten, E. F., & Fuss, I. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5061-0_3 · Cited by 8
Femia, A. P., Swidsinski, A. V., Dolara, P., Salvadori, M., Amedei, A., & Caderni, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029918 · Cited by 7
“. Regarding carcinogenesis in association with colitis, some studies indicated that Tlrs may have a protective role”
BackgroundSulaiman, G., Cooke, A. A., Ffrench, B., Gasch, C., Abdullai, O. A., O’Connor, K., Elbaruni, S. A., Blackshields, G., Spillane, C. D., Keegan, H., et al. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.124 · Cited by 6
Arnold, M. G., Gokulan, K., Doerge, D. R., Vanlandingham, M. M., Cerniglia, C. E., & Khare, S. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.110597 · Cited by 6
Whitehead, L., & Brown, G. D. (2017) · Wiley-VCH eBooks · doi:10.1002/9783527692156.ch8 · Cited by 7
Clinical Detection and Management of Colorectal Cancer Concerning the Gut Microbiome
Farahani, H. E., Pourhajibagher, M., & Bahador, A. (2025) · Scientifica · doi:10.1155/sci5/1945321 · Cited by 6
“Butyrate supports gut health by activating the GPR109a receptor in epithelial cells, which induces IL-18 synthesis, aiding mucosal healing and maintaining gut barrier integrity [67].”
Inulin aggravates colitis through gut microbiota modulation and MyD88/IL-18 signaling
Zhao, X., Wang, Y., Wang, Y., Gewirtz, A. T., & Zou, J. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2570425 · Cited by 5
“12,13 Activation of MyD88-dependent pathways by microbial components can induce IL-18 production that can maintain barrier integrity.”
Deep resequencing identifies candidate functional genes in leprosy GWAS loci
Fava, V. M., Dallmann-Sauer, M., Orlova, M., Correa-Macedo, W., Thuc, N. V., Thai, V. H., Alcaïs, A., Abel, L., Cobat, A., & Schurr, E. (2021) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0010029 · Cited by 5
“On the one hand, studies with knock-out mice suggested a critical role of IL18 in protection from intestinal inflammation and colitis while on the other hand IL18 was shown to promote goblet cell dysfunction and breakdown of the mucosal barrier [43,44].”
BackgroundToll‐like receptor 13‐mediated signaling protects against the development of colon cancer
Rafique, A., Ali, İ., Kim, S., Farooq, A., Manzoor, U., Moon, J., Arooj, M., Ahn, M., Park, Y., Hyun, C. L., et al. (2024) · International Journal of Cancer · doi:10.1002/ijc.35089 · Cited by 5
“47 Similarly, TLR2 may create a suppressive environment for CAC development in the intes-tines.”
MyD88's function in the emergence and growth of tumors
Liu, J., Zhu, S., Huang, Q., Yao, Y., Li, W., & Zhang, S. (2024) · Clinical Cancer Bulletin · doi:10.1007/s44272-024-00023-x · Cited by 5
“Further studies reveal that intestinal epithelial cells in a MyD88 − / − mouse model are more sensitive to AOM/ DSS than those in wild type mice, and are more likely to induce CAC [39].”
InfluentialAchilonu, C. C., Ramatla, T. A., Maleke, M., Kumar, P., Igbalajobi, O. A., & Noel, C. B. (2025) · Current Clinical Microbiology Reports · doi:10.1007/s40588-024-00239-4 · Cited by 5
“However, the inactivation of MyD88 protein in mice ( MyD88 − / − ) led to a reduction in their ability to repair mucous membranes after injury [59].”
IL-1R2 promotes tumorigenesis and modulates the tumor immune microenvironment in colorectal cancer
Lang, Y., Huang, H., Jiang, H., Wu, S., Zhang, F., Zhang, D., Qian, H., Liu, Y., Yuan, M., Xu, B., et al. (2025) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-025-04138-5 · Cited by 5
Neufeld, K. L., & Zeineldin, M. (2015) · Gastrointestinal Cancer Targets and Therapy · doi:10.2147/gictt.s51386 · Cited by 5
“Reducing microbial-induced inflammation by deleting the PAMP pathway adaptor protein Myd88 decreases intestinal tumors in ApcMin/+ mice and colon tumors in AOM-treated mice.(179,180) Furthermore, transplantation of bone marrow from mice with mutations in genes encoding PAMP adaptor proteins Myd88, Tlr2, 4, and 9 reduc…”
Microbiota, mucosal immunity, and Colon cancer
Drewes, J. L., Domingue, J. C., & Housseau, F. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819672-4.00008-8 · Cited by 5
Investigating the Influence of Gut Microbiota-related Metabolites in Gastrointestinal Cancer
Marzhoseyni, Z., Shaghaghi, Z., Alvandi, M., & Shirvani, M. (2024) · Current Cancer Drug Targets · doi:10.2174/0115680096274860231111210214 · Cited by 4
Cancer Pathogenesis and DNA Sensing
Shen, Y. J., Lam, A. R., Ho, S. W. S., Koo, C. X., Bert, N. L., & Gasser, S. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-404732-7.00009-5 · Cited by 5
Downregulation of adaptor protein MyD88 compromises the angiogenic potential of B16 murine melanoma
Trucco, L. D., Roselli, E., Araya, P., Núñez, N. G., Mena, H. A., Bocco, J. L., Negrotto, S., & Maccioni, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179897 · Cited by 8
Gut Microbiota and Cancer Correlates
Malaviya, A., Paari, K. A., Malviya, S., Kondapalli, V. K., Ghosh, A., & Samuel, R. A. (2020) · Springer eBooks · doi:10.1007/978-981-15-8214-1_1 · Cited by 5
Mucosal Bacterial Recognition and Signaling Systems in the Intestine
Fukata, M., & Abreu, M. T. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382026-6.00041-5 · Cited by 9
Arnold, C. M., Kienes, I., Sowa, A. S., & Kufer, T. A. (2018) · Wiley eBooks · doi:10.1002/9780470015902.a0026236 · Cited by 5
The Influence of the Microbiota on the Etiology of Colorectal Cancer
Kordahi, M. C., & DePaolo, R. W. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7534-1_8 · Cited by 3
The Microbiota: A New Player in the Etiology of Colorectal Cancer
Levy, M., Thaiss, C. A., & Elinav, E. (2013) · Current Colorectal Cancer Reports · doi:10.1007/s11888-013-0196-z · Cited by 3
Immunologic Drivers and Restraints in Colitis-Associated Colorectal Cancer
Frascatani, R., Laudisi, F., Stolfi, C., & Monteleone, G. (2026) · Cancers · doi:10.3390/cancers18081230 · Cited by 2
Inflammation and Colorectal Cancer
Dheer, R., Davies, J. M., & Abreu, M. T. (2015) · Springer eBooks · doi:10.1007/978-3-319-19986-3_8 · Cited by 3
Evaluation of Toll-like receptors expression in terms of colon cancer
Dzhenkova, E. A., Арменовна, М. Э., Sagakyants, A. B., Bondarenko, E. S., Zlatnik, E. Y., Av, S., Kolesnikov, E. N., Kaymakchi, O. Y., Dashkov, A. V., Kaminskiy, G. V., et al. (2022) · Research and Practical Medicine Journal · doi:10.17709/2410-1893-2022-9-4-6 · Cited by 2
Liu, Z., Zhu, H., Zhang, F., Huang, W., Zhu, S., He, S., Yao, Y., Song, Q., & Zhang, X. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1554705 · Cited by 2
Wang, Z., Chen, T., Shi, H., Zhang, X., & Yang, W. (2025) · Health Science Reports · doi:10.1002/hsr2.70803 · Cited by 2
“Research suggests that a complete absence of IL ‐ 18 (or its receptor IL ‐ 18R) makes mice more susceptible to intestinal epithelial harm, and creates a modified inflammatory milieu that enhances the potential for intestinal tumor development [48, 49].”
Inflammasomes and Inflammation
Chen, K. W., Richards, A. A., Zamoshnikova, A., & Schroder, K. (2014) · Wiley eBooks · doi:10.1002/9781118826621.ch8 · Cited by 2
Immunology and Immunotherapy of Colorectal Cancer
Varela‐Calviño, R., & Cordero, O. J. (2015) · Springer eBooks · doi:10.1007/978-3-662-46410-6_11 · Cited by 2
Intestinal Inflammation and Cancer of the Gastrointestinal Tract
Neurath, M. F., Fichtner‐Feigl, S., & Kesselring, R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-415847-4.00091-4 · Cited by 2
Cytokines and Inflammatory Bowel Disease
de Zoeten, E. F., & Fuss, I. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-49215-5_3 · Cited by 3
Modulation of the innate immune response by the oncoviruses EBV and HPV
Parroche, P. (2011) · theses.fr (ABES) · doi:10.70675/1123b896zdfdaz408az9372z41cc116e27df · Cited by 3
IL-18: Regulation and Physiological Roles of IL-18
Li, W., Tanaka, Y., & Okamura, H. (2013) · Springer eBooks · doi:10.1007/978-4-431-54442-5_4 · Cited by 1
Cytokines and Inflammatory Bowel Disease
de Zoeten, E. F., & Fuss, I. J. (2023) · Springer eBooks · doi:10.1007/978-3-031-14744-9_3 · Cited by 3
Interleukin-18 armours antitumour immune effectors
Sharma, A., Bishara, G. G., Olejniczak, S. H., Ohm, J. E., Brentjens, R. J., & Gupta, A. K. (2026) · Nature reviews. Immunology · doi:10.1038/s41577-026-01330-1 · Cited by 1
Helmy, M., Alafifi, A. M., & Ali, A. H. (2009) · PubMed · Cited by 1
Innate Immune Signaling and Negative Regulators in Cancer
Wang, H. Y., & Wang, R. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9914-6_6 · Cited by 1
INFLAMMATION AND INTESTINAL HOMEOSTASIS-ASSOCIATED GENES IN COLORECTAL CANCER
Ungerbäck, J. (2012) · DiVA (Linkoping University) · Cited by 1
Inflammatory Mediators in Tumorigenesis and Metastasis
Dupaul-Chicoine, J., & Saleh, M. (2013) · Springer eBooks · doi:10.1007/978-1-4614-3685-0_9 · Cited by 1
NOD-Like Receptors in Colon Tumorigenesis
Zaki, H. (2013) · ImmunoGastroenterology · doi:10.7178/ig.35 · Cited by 1
Colorectal Adenocarcinoma and Inflammatory Bowel Disease: An Update and Review
Karmali, M. L. S. (2015) · Surgery Current Research · doi:10.4172/2161-1076.1000249 · Cited by 1
“MYD88knockout mice were shown to be highly susceptible to the development adenocarcinoma of the colon in some experiments [31] but decrease intestinal tumorgenesis in other models [32,33].”
BackgroundKinowaki, K., Soejima, Y., Kumagai, A., Kondo, F., Sano, K., Fujii, T., Kitagawa, M., & Fukusato, T. (2017) · Pathology International · doi:10.1111/pin.12529 · Cited by 3
Yin, J., Dong, C., Tang, W., Liu, R., Chen, S., Liang, Z., & Gu, H. (2017) · Molecular and Clinical Oncology · doi:10.3892/mco.2017.1469 · Cited by 1
Role of Inflammasomes in the Development of Gastrointestinal Diseases
Kanak, M. A., Shindo, Y., SaiKumar, P., & Naziruddin, B. (2018) · Experientia supplementum · doi:10.1007/978-3-319-89390-7_10 · Cited by 2
Positive and Negative Effects of the Commensal Bacteria on Carcinogenesis
Lafta, I. J., & Alkaabawi, N. A. M. (2019) · Sudan Journal of Medical Sciences · doi:10.18502/sjms.v14i2.4688 · Cited by 1
“And finally, the gut microbiota itself is required for an efficient mucosal repair following epithelial damage [30].”
BackgroundGut Microbiome and Immune Responses in Gastrointestinal Cancer
Laube, R., & Liu, K. (2023) · Springer eBooks · doi:10.1007/978-981-19-4492-5_11 · Cited by 1
Role of the Inflammasome in Cancer
Terlizzi, M., Colarusso, C., Pinto, A., & Sorrentino, R. (2020) · Springer eBooks · doi:10.1007/978-3-030-30845-2_15 · Cited by 1
Piefer, L. A. (2012) · OakTrust (Texas A&M University Libraries) · Cited by 1
Role of NLRP3 in colitis and colitis associated colorectal cancer
Perera, A. P. (2019) · UTAS Research Repository · doi:10.25959/100.00034330 · Cited by 1
Huang, T. H., Ma, Y., Montal, E. D., Suresh, S., Tagore, M. M., Corbin, A. F., Lumaquin, D., Campbell, N. R., Baggiolini, A., Koche, R. P., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.16.496450 · Cited by 1
“reducing tumor progression or chemical carcinogenesis via modulating the host immunity (Ahmed et al., 2013; Salcedo et al., 2010; Yusuf et al., 2008), which seem to be contradictory to the growing evidence in the correlation of elevated TLR4/MyD88 with advanced stages and poor prognosis in various cancers (Chen et al.”
BackgroundKaci, G. (2012) · theses.fr (ABES) · doi:10.70675/3415a327z542cz4f6eza918z918d7f2d2627 · Cited by 1
Piste infectieuse à Escherichia coli toxinogènes dans le cancer colorectal
Raisch, J. (2014) · theses.fr (ABES) · doi:10.70675/d8946435z5f92z4b9az894az6d7593f00e77 · Cited by 1
Anti-tumor and pro-tumor interactions of human NK cells in cancer
Wong, J. L. (2013) · D-Scholarship@Pitt (University of Pittsburgh)
Expression of adipocyte/macrophage fatty acid binding protein promotes tumor growth and metastasis.
Triplett, A. (2012) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/1457
Étude du rôle de l’autophagie dans la cancérogenèse intestinale
Levy, J. (2014) · theses.fr (ABES) · doi:10.70675/2a7b0f33zed43z4b27z8afaz3b6a980e5541
Metadata
- Authors
- Salcedo, R., Worschech, A., Cardone, M., Jones, Y., Gyulai, Z., Dai, R.-M., Wang, E., Ma, W., Haines, D., O'hUigin, C., Marincola, F. M., & Trinchieri, G.
- Affiliations
- National Cancer Institute (US)
- National Institutes of Health (US)
- Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21701 1
- Science Applications International Corporation (United States) (US)
- Corresponding author
- Trinchieri, Giorgio
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2010-07-12
- Volume
- 207
- Issue
- 8
- Pages
- 1625-1636
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2916129
- OpenAlex
- W2118983602
- Cited by
- 429
- References
- 44
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 10 · 2023: 24 · 2022: 21 · 2021: 24 · 2020: 26 · 2019: 21 · 2018: 38 · 2017: 38 · 2016: 18 · 2015: 35 · 2014: 36 · 2013: 42 · 2012: 37
- FWCI
- 16.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (HHSN261200800001C)
- National Cancer Institute (HHSN261200800001E))
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- MyD88 signaling, IL-18, interleukin-18 receptor, colitis-associated colorectal cancer, colon adenocarcinoma, carcinogenesis, inflammatory bowel disease, CTNNB1 mutation, adenoma formation, MyD88-deficient mice, TLR2, TLR4, tissue homeostasis
- MeSH terms
- Adenocarcinoma, Animals, Azoxymethane, Colon, Colonic Neoplasms, Colonic Polyps, Epithelial Cells, Intestinal Mucosa, Mice, Inbred C57BL, Mutation, Phosphorylation, Specific Pathogen-Free Organisms, Inflammatory Bowel Diseases, Signal Transduction, Gene Expression, Dextran Sulfate, Apoptosis, Mice, Knockout, Genetic Predisposition to Disease, Interleukin-18, Gene Expression Profiling, DNA Repair Enzymes, Cell Proliferation, STAT3 Transcription Factor, beta Catenin, Mice, Cyclooxygenase 2, Receptors, Interleukin-1 Type I, Myeloid Differentiation Factor 88, Interleukin-18 Receptor alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.